KYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q2 2024

Date:

August 13, 2024

Kyverna Therapeutics (NASDAQ:KYTX) just reported results for the second quarter of 2024.

Kyverna Therapeutics reported earnings per share of -67 cents. This was below the analyst estimate for EPS of -64 cents.
The company did not report any revenue for the quarter.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q2 2024

SNWV Stock Earnings: SANUWAVE Health Reported Results for Q2 2024